Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 9,136 | 4,433 | 7,361 | 36,475 | 11,324 |
| Cost of Goods | 864 | 163 | 160 | 190 | 736 |
| Gross Profit | 8,272 | 4,270 | 7,201 | 36,285 | 10,588 |
| Operating Expenses | 14,694 | 33,097 | 26,428 | 32,348 | 37,527 |
| Operating Income | -5,558 | -28,664 | -19,067 | 4,127 | -26,203 |
| Interest Expense | 589 | 634 | 677 | 714 | -275 |
| Other Income | -414 | -63 | -278 | -422 | -88 |
| Pre-tax Income | -6,561 | -29,361 | -20,022 | 2,991 | -26,016 |
| Net Income Continuous | -6,561 | -29,361 | -20,022 | 2,991 | -26,016 |
| Minority Interests | -189 | -178 | -256 | -321 | -379 |
| Net Income | $-6,372 | $-29,183 | $-19,766 | $3,312 | $-25,637 |
| EPS Basic Total Ops | -0.23 | -1.04 | -0.71 | 0.12 | -1.11 |
| EPS Basic Continuous Ops | -0.24 | -1.05 | -0.72 | 0.11 | -1.00 |
| EPS Diluted Total Ops | -0.23 | -1.04 | -0.71 | 0.12 | -1.11 |
| EPS Diluted Continuous Ops | -0.24 | -1.05 | -0.72 | 0.11 | -1.00 |
| EBITDA(a) | $-5,363 | $-28,470 | $-18,857 | $4,359 | $-25,970 |